Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$5.33 - $8.18 $558,525 - $857,174
-104,789 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$5.5 - $9.19 $7.9 Million - $13.2 Million
-1,436,317 Reduced 93.2%
104,789 $742,000
Q4 2021

Feb 14, 2022

BUY
$7.67 - $44.59 $11.7 Million - $68 Million
1,525,824 Added 9984.45%
1,541,106 $13.8 Million
Q2 2021

Aug 13, 2021

SELL
$19.22 - $59.08 $231,466 - $711,500
-12,043 Reduced 44.07%
15,282 $328,000
Q1 2021

May 17, 2021

BUY
$41.42 - $88.44 $1.13 Million - $2.42 Million
27,325 New
27,325 $1.69 Million

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $255M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.